Stock FOLD AMICUS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Amicus Therapeutics, Inc.

Equities

FOLD

US03152W1099

Real-time Estimate Cboe BZX
Other stock markets
 02:27:42 2024-05-08 pm EDT 		5-day change 1st Jan Change
10.18 USD -2.35% Intraday chart for Amicus Therapeutics, Inc. -2.35% -28.22%
Mar. 18 JPMorgan Adjusts Price Target on Amicus Therapeutics to $19 From $21, Maintains Overweight Rating MT
Mar. 05 Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amicus Therapeutics Insider Sold Shares Worth $389,543, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $390,018, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $683,958, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $404,106, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $934,659, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $449,545, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $734,007, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $490,411, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $253,542, According to a Recent SEC Filing
MT
Amicus Therapeutics Insider Sold Shares Worth $129,693, According to a Recent SEC Filing
MT
Amicus Therapeutics Announces Executive Changes
CI
Amicus Therapeutics Insider Sold Shares Worth $131,489, According to a Recent SEC Filing
MT
Amicus Therapeutics Names Simon Harford CFO
MT
Insider Sell: Amicus Therapeutics
MT
Insider Sell: Amicus Therapeutics
MT
Amicus Therapeutics, Inc. Appoints Samantha Prout as Chief Accounting Officer and Controller
CI
Insider Sell: Amicus Therapeutics
MT
Insider Sell: Amicus Therapeutics
MT
Insider Sell: Amicus Therapeutics
MT
Insider Sell: Amicus Therapeutics
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FOLD Stock
  4. News Amicus Therapeutics, Inc.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW